Stock Events

Stock Events

Moberg Pharma AB 

€0.000000
0
+€0.00+0% 00:00 Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13AugExpected
Q1 2026
Next
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

-201.86%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.23MRevenue
-2.49MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MB8A.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap633.19B
Johnson & Johnson operates in the pharmaceuticals sector, offering a wide range of healthcare products that compete with Moberg Pharma's offerings.
Pfizer
PFE
Mkt Cap138.61B
Pfizer is a global biopharmaceutical company with a portfolio that includes treatments in areas similar to those targeted by Moberg Pharma.
Novartis
NVS
Mkt Cap305.1B
Novartis is a multinational pharmaceutical company that produces drugs in many of the same categories as Moberg Pharma.
GSK
GSK
Mkt Cap107.47B
GlaxoSmithKline is a healthcare company that develops and markets drugs and vaccines in various areas, including those competing with Moberg Pharma.
Merck
MRK
Mkt Cap319.99B
Merck & Co., Inc. is a global healthcare company that offers products in areas that overlap with Moberg Pharma's therapeutic focus.
Abbvie
ABBV
Mkt Cap461.26B
AbbVie is a biopharmaceutical company with a broad range of medical products that compete in the same market as Moberg Pharma.
Sanofi
SNY
Mkt Cap103.32B
Sanofi is a global healthcare leader that offers drugs in many of the same therapeutic areas as Moberg Pharma.
AMGEN
AMGN
Mkt Cap201.93B
Amgen is a biotechnology company focused on developing novel treatments, some of which compete with Moberg Pharma's products.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap40.34B
Teva Pharmaceutical Industries is a global leader in generic and specialty medicines, competing directly in some of the markets targeted by Moberg Pharma.

About

Moberg Pharma AB (publ), a pharmaceutical company, develops and commercializes medical products primarily in Sweden. It offers MOB-015 for the treatment of nail fungus under the Terclara brand. The company was formerly known as Moberg Derma AB (publ) and changed its name to Moberg Pharma AB (publ) in May 2013. It has license agreement with Karo Healthcare for distribution in European market. Moberg Pharma AB (publ) was incorporated in 2006 and is based in Bromma, Sweden.
Show more...
CEO
Ms. Anna Ljung BA, M.Sc.
Employees
11
Country
Sweden
ISIN
SE0013121340

Listings

STU
DE
MB8.STU
MU
DE
MB8A.MU
MU
DE
MB8.MU
F
DE
MB8.F

0 Comments

Share your thoughts

FAQ

What is Moberg Pharma AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Moberg Pharma AB stocks are traded under the ticker MB8A.MU.
When is the next Moberg Pharma AB earnings date?▼
Moberg Pharma AB is going to release the next earnings report on August 13, 2026.
What is Moberg Pharma AB revenue for the last year?▼
Moberg Pharma AB revenue for the last year amounts to 1.23M EUR.
What is Moberg Pharma AB net income for the last year?▼
MB8A.MU net income for the last year is -2.49M EUR.
How many employees does Moberg Pharma AB have?▼
As of July 10, 2026, the company has 11 employees.
In which sector is Moberg Pharma AB located?▼
Moberg Pharma AB operates in the Other sector.
When did Moberg Pharma AB complete a stock split?▼
Moberg Pharma AB has not had any recent stock splits.
Where is Moberg Pharma AB headquartered?▼
Moberg Pharma AB is headquartered in Bromma, Sweden.